Day One Biopharmaceuticals, Inc. (DAWN)

NASDAQ: DAWN · IEX Real-Time Price · USD

13.21

-1.98 (-13.03%)

At close: Apr 25, 2024, 4:00 PM

13.73

+0.52 (3.94%)

After-hours: Apr 25, 2024, 7:59 PM EDT

DAWN Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-188.92	-142.18	-170.64	-40.51	-12.63
Depreciation & Amortization	0.38	0.53	0.2	0.16	0
Share-Based Compensation	39.34	27.24	13.32	0.53	0.11
Other Operating Activities	2.34	4.53	108.58	26.34	12.36
Operating Cash Flow	-146.85	-109.87	-48.54	-13.49	-4.52
Capital Expenditures	-0.22	-0.03	0	-0.09	0
Acquisitions	-3	0	-8	0	0
Change in Investments	131.6	-255.05	0	0	0
Investing Cash Flow	128.38	-255.07	-8	-0.09	0
Share Issuance / Repurchase	162.66	162.25	167.36	0	0
Debt Issued / Paid	0	0	0	0	1
Other Financing Activities	1.34	3.65	129.76	29.98	29.91
Financing Cash Flow	164	165.9	297.12	29.98	30.91
Net Cash Flow	145.52	-199.05	240.58	16.4	26.39
Free Cash Flow	-147.08	-109.9	-48.54	-13.58	-4.52
Free Cash Flow Per Share	-1.84	-1.68	-1.31	-2.46	-0.76

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).